# FDA Inspection 1047630 - ImpactLife - March 20, 2018

Source: https://www.globalkeysolutions.net/records/fda_inspections/impactlife/f8375532-803f-4974-bdea-469b592fc702/
Source feed: FDA_Inspections

> FDA Inspection 1047630 for ImpactLife on March 20, 2018. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1047630
- Company Name: ImpactLife
- Inspection Date: 2018-03-20
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1115857 - 2020-01-14](https://www.globalkeysolutions.net/api/records/fda_inspections/impactlife/bb361849-a210-49c3-ab66-a8e56b399f3f/)
- [FDA Inspection 955078 - 2015-12-08](https://www.globalkeysolutions.net/api/records/fda_inspections/impactlife/8de37a5e-1db4-4801-bf4d-161cd533bfd5/)
- [FDA Inspection 855749 - 2013-11-25](https://www.globalkeysolutions.net/api/records/fda_inspections/impactlife/a0ee83f1-2fbb-400e-8cb2-2b7707acb381/)

Company: https://www.globalkeysolutions.net/companies/impactlife/b67d007d-626e-469c-987a-2f17e74ea357

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d